Dr. David M. Devilbiss is the co-founder and Head of Research and Development at Cerora. He also holds a faculty appointment at the University of Wisconsin in the Department of Psychology and previously founded a neurophysiological diagnostic company for animal models of disease. Dr. Devilbiss is one of the world’s leading neuroscientists focused on understanding the relationship between the electrical activity of the brain and its modulation by pharmacological therapeutics used to treat cognitive dysfunction. His efforts to bridge leading academic universities and industry research organizations continue to advance the technologies and approaches to identify and treat neuropsychiatric diseases. As head of R&D for Cerora, he applies a multidisciplinary approach to combine recordings of electrical activity of the brain during cognitive testing with computational modeling to deliver assessments of brain function in a highly portable and easy to use technology platform in real time.
David Devilbiss
